CAS: 1234708-04-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide REF: AN-AG009CIBCAS: 1234708-04-3 | 98% | 762,00 €~2.327,00 € | Mié 08 May 24 |
 | hPGDS-IN-1 REF: TM-T2681CAS: 1234708-04-3 | 100% | 111,00 €~2.274,00 € | Mié 15 May 24 |
 | SAR191801 REF: 3D-JZB70804CAS: 1234708-04-3 | Min. 95% | A consultar | Jue 20 Jun 24 |
N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide
CAS:1234708-04-3
Fórmula:
C22H20N6O3
Pureza:
98%
Peso molecular:
416.4326
Ref: AN-AG009CIB
| 10mg | 762,00 € | |
| 25mg | 1.294,00 € | |
| 50mg | 2.327,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
hPGDS-IN-1
CAS:1234708-04-3
hPGDS-IN-1 is a hPGDS inhibitor.
Fórmula:
C22H20N6O3
Pureza:
100%
Forma y color:
Solid
Peso molecular:
416.43
Ref: TM-T2681
| 1mg | 111,00 € | |
| 5mg | 230,00 € | |
| 10mg | 348,00 € | |
| 25mg | 585,00 € | |
| 50mg | 832,00 € | |
| 100mg | 1.133,00 € | |
| 500mg | 2.274,00 € | |
| 1ml*10 (DMSO) | 254,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
SAR191801
CAS:1234708-04-3
Please enquire for more information about SAR191801 including the price, delivery time and more detailed …
Fórmula:
C22H20N6O3
Pureza:
Min. 95%
Peso molecular:
416.43 g/mol
Ref: 3D-JZB70804
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
